Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory AscitesNCT04112199BIVIPhase 2Terminated2023-05-08Actual
Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the KneeNCT04120402EPRXPhase 2Completed2023-05-17Actual
A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X AlleleNCT04126473ELOXPhase 2Completed2022-04-06Actual
A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic PhaseNCT04126681Ascentage Pharma Group Inc.Phase 2Completed2024-08-01Actual
OCS-01 in Treating Inflammation and Pain in Post-cataract PatientsNCT04130802OculisPhase 2Completed2020-01-31Actual
An Extension Study of Ublituximab in Participants With Relapsing Multiple SclerosisNCT04130997TGTXPhase 3Active not recruiting2032-05-31Estimated
The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic SteatohepatitisNCT04134091LPCNPhase 2Completed2021-06-24Actual
Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for DialysisNCT04135417HUMAPhase 2Completed2021-05-15Actual
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)NCT04136171IONSPhase 3Completed2026-03-25Actual
NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid PolyneuropathyNCT04136184IONSPhase 3Completed2023-04-11Actual
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative VitreoretinopathyNCT04136366ALDXPhase 3Completed2022-06-14Actual
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)NCT04140695Vanda PharmaceuticalsPhase 3Terminated2020-10-14Actual
PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on ApixabanNCT04142658AORTPhase 3Terminated2022-12-12Actual
Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHDNCT04143217SUPNPhase 3Completed2022-07-26Actual
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)NCT04145531Jazz PharmaceuticalsPhase 2, Phase 3Completed2022-07-13Actual
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)NCT04146051Cartesian TherapeuticsPhase 2Active not recruiting2026-01-05Actual
A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCCNCT04155190SLGLPhase 2Terminated2021-04-23Actual
Initiating Early Control of Migraine Pain and Associated SymptomsNCT04163185AXSMPhase 3Completed2020-03-16Actual
MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat StudyNCT04168385MIRMPhase 2Completed2024-09-04Actual
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASHNCT04173065VKTXPhase 2Completed2023-05-15Actual
Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)NCT04181723ACADPhase 3Completed2021-10-28Actual
An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)NCT04185363MIRMPhase 3Completed2025-04-23Actual
A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult SubjectsNCT04196101ENTAPhase 2Completed2022-01-04Actual
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease PatientsNCT04197479MDGLPhase 3Completed2023-01-06Actual
PTG-300 in Subjects With Hereditary HemochromatosisNCT04202965PTGXPhase 2Completed2021-10-06Actual
Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple SclerosisNCT04203498Jazz PharmaceuticalsPhase 3Terminated2023-02-10Actual
Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"NCT04204252KMDAPhase 3Terminated2026-02-19Actual
The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.NCT04207736ALDXPhase 3Completed2021-02-16Actual
A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 StudyNCT04215146Oncolytics BiotechPhase 2Active not recruiting2022-08-01Actual
Actuate 1901: 9-ING-41 in MyelofibrosisNCT04218071ACTUPhase 2Completed2022-10-13Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.